Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology

被引:0
|
作者
Muller-Quernheim, J [1 ]
机构
[1] Hosp Med, Res Ctr Borstel, D-23845 Borstel, Germany
关键词
sarcoidosis; idiopathic pulmonary fibrosis; collagen-vascular diseases; serum markers; alveolitis; immunopathogenesis;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Immunopathogenic mechanisms in sarcoidosis, idiopathic pulmonary fibrosis, and pulmonary manifestations of collagen-vascular diseases maintain an alveolitis which may lead to irreversible organ damage. The classical parameters used in the management of pulmonary involvement of these disorders are chest X-ray and pulmonary function test which do not gauge alveolitis but rather pulmonary impairment. From the immunopathogenesis several serological parameters have been delineated estimating different aspects of inflammatory processes. Cytokines, soluble cytokine receptors, metabolites, enzymes, extracellular matrix components, soluble adhesion molecules, and other serum components have been evaluated to serve as serological markers of alveolitis. The mechanisms gauged by these markers, and their clinical usefulness are discussed in this review.
引用
收藏
页码:22 / 37
页数:16
相关论文
共 50 条
  • [21] MicroRNAs in serum of Interstitial lung diseases patients
    Shepelkova, Galina
    Evstifeev, Vladimir
    Zaytseva, Anna
    Adamovskaya, Evgenia
    Guskov, Alexander
    Stepanyan, Igor
    Shmelev, Evgeniy
    Yeremeev, Vladimir
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [22] Serum Biomarkers in Diffuse Interstitial Lung Diseases
    Sellares, Jacobo
    Molina-Molina, Maria
    ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (06): : 349 - 350
  • [23] Telomerase activity in bronchoscopic samples from patients with sarcoidosis and interstitial lung disease.
    Ramakrishna, R
    Aldous, WK
    Marean, A
    Dillard, TA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A339 - A339
  • [24] EXERCISE RESPONSE IN PATIENTS WITH SARCOIDOSIS AND INTERSTITIAL LUNG DISEASE
    CLARK, RA
    THORAX, 1969, 24 (03) : 381 - &
  • [25] Lung transplantation in pulmonary fibrosis and other interstitial lung diseases
    Berastegui, Cristina
    Monforte, Victor
    Bravo, Carlos
    Sole, Joan
    Gavalda, Joan
    Tenorio, Luis
    Villar, Ana
    Isabel Rochera, M.
    Canela, Merce
    Morell, Ferran
    Roman, Antonio
    MEDICINA CLINICA, 2014, 143 (06): : 239 - 244
  • [26] Identification of Early Pathologic Markers of Interstitial Lung Diseases
    Sholl, L. M.
    Fernandez, I. E.
    Rosas, I. O.
    Padera, R. F.
    MODERN PATHOLOGY, 2010, 23 : 413A - 414A
  • [27] Identification of Early Pathologic Markers of Interstitial Lung Diseases
    Sholl, L. M.
    Fernandez, I. E.
    Rosas, I. O.
    Padera, R. F.
    LABORATORY INVESTIGATION, 2010, 90 : 413A - 414A
  • [28] Diagnostic approach of fibrosing interstitial lung diseases of unknown origin
    Cottin, Vincent
    Valenzuela, Claudia
    PRESSE MEDICALE, 2020, 49 (02):
  • [29] Is The Neutrophil-To-Lympocyte Ratio Different In Sarcoidosis And Interstitial Lung Diseases?
    Karakurt, Z.
    Akturk, U. Aka
    Kocak, N. Durmus
    Yalcinsoy, M.
    Gungor, S.
    Aksoy, E.
    Karakurt, Z.
    Gundogus, B.
    Sertcelik, L.
    Agca, M. Coban
    Duman, D.
    Oztas, S.
    Yavuz, D.
    Ozgen, H.
    Sevim, T.
    Akkaya, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [30] Chitotriosidase activity in sarcoidosis and some other pulmonary diseases
    Tercelj, Marjeta
    Salobir, Barbara
    Simcic, Sasa
    Wraber, Branka
    Zupancic, Mirjana
    Rylander, Ragnar
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2009, 69 (05): : 575 - 578